Soros Fund Management Raises Stake in PlasmaTech Biopharmaceuticals (PTBI) to 5.17%

May 4, 2015 5:11 PM EDT

In a 13G filing on PlasmaTech Biopharmaceuticals (NASDAQ: PTBI), hedge fund Soros Fund Management disclosed a 5.17%, or 1,166,667 share, stake in the company. This is up 366.67% from the 250,000 shares held at the end of the latest quarter ending Dec. 31, 2014.

For more notable holders of PlasmaTech Biopharmaceuticals stock click here. For more information on Soros Fund Management click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

13Gs, Hedge Funds, Hot Hedge Fund News, Trader Talk

Related Entities

Soros Fund Management, 13G